In a progeroid environment (BubR1H/H mice), Baker et al.353 demonstrated that eliminating cells expressing the senescence-marker gene Cdkn2a (p16) delayed the development of age-related symptoms such as sarcopenia, cataracts, and adipose tissue loss. Here, CDKN2A is linked to sarcopenia.